Medacta Group Rg
MOVE
CHF
STOCK MARKET:
SWX
Closed
 
...
Large gap with delayed quotes
Last quote
01/06/2025 - 17:31:17
Bid
01/06/2025 - 17:17:49
Bid
Volume
Ask
01/06/2025 - 19:05:22
Ask
Volume
115.00
+4.80 ( +4.36% )
115.40
92
117.80
700
More information
Analysis by TheScreener
03.01.2025
Evaluation Neutral  
Interest Weak  
Sensibility Middle  
Analysis date: 03.01.2025
Global Evaluation
  Neutral
The stock is classified in the neutral zone since 06.12.2024.
Interest
  Weak
Weak interest since 03.01.2025.
Earnings Rev Trend
  Positive
 
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 03.01.2025 at a price of 110.20.
Evaluation
  Overvalued
 
Based on its growth potential and our own criteria, at its current price the stock is moderately overvalued.
MT Tech Trend
  Neutral
 
The stock is currently trading close to its forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this (since 06.09.2024), the stock traded below its moving average. The confirmed Technical Reverse (Tech Reverse + 1.75%) point is .
4wk Rel Perf
  3.46%
 
The four week relative overperformance versus STOXX600 is 3.46%.
Sensibility
  Middle
Moderate, no change over 1 year.
Bear Market Factor
  Middle
On average, the stock is likely to decline with the index.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 1.68%.
Mkt Cap in $bn
  2.42
With a market capitalization between $2 & $8bn, MEDACTA GROUP is considered a mid-cap stock.
G/PE Ratio
  0.83
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential: premium.
LT P/E
  23.03
The estimated PE is for the year 2026.
LT Growth
  18.22%
The annualized growth estimate is for the current year to 2026.
Avg. Nb analysts
  3
Over the last seven weeks, an average of 3 analysts provided earnings per share estimates.
Dividend Yield
  0.82%
The twelve month estimated dividend yield represents 18.81% of earnings forecasts.
Beta
  79
For 1% of index variation, the stock varies on average by 0.79%.
Correlation
  0.42
41.95% of stock movements are explained by index variations.
Value at Risk
  13.24
The value at risk is estimated at CHF 13.24. The risk is therefore 12.01%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  20.09.2019